First line treatment in HIV-related diffuse large cell non Hodgkin Lymphoma at ''high risk'', including early consolidation with high dose chemotherapy and autologous peripheral blood stem cell transplantation - ND
Phase 1
- Conditions
- diffuse large cell lymphoma HIV infection relatedMedDRA version: 6.1Level: PTClassification code 10025312
- Registration Number
- EUCTR2006-006047-30-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
-age<61years -LNH HIV related -IPI: 2-3 -stage IB-IV
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
-LNH Burkitt or Lymphoblastic -IPI: 0-1 -cardiac, respiratory, hepatic, renal failure -bone marrow failure -lymphoma localized at SNC
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method